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Abstracts / Urological Science 26 (2015) S1eS25 S15experienced about a three-fold increased risk of bladder recurrence as
compared to those without both factors (HR: 3.222; p< 0.001). Patients
with either one of the two risk factors experienced about a two-fold
increased risk as compared to those without both factors (with DM, HR:
2.184, p ¼ 0.024; with ureteral involvement, HR: 2.006, p ¼ 0.003).
Conclusion: Ureteral involvement and DM are signiﬁcantly related to
bladder recurrence after RNU in patients with UUT-UC.
PD8-2:
HYDRONEPHROSIS INDEPENDENTLY PREDICTS WORSE OUTCOME OF
UPPER TRACT UROTHELIAL CARCINOMA IN PATIENTS PRESENTING
WITH SIMULTANEOUS FLANK PAIN
Hsin-Chih Yeh 1,2, Ching-Chia Li 1,2, Chun-Nung Huang 2, Hung-Lung
Ke 2, Wei-Ming Li 2, Wen-Jeng Wu 2. 1Department of Urology, Kaohsiung
Municipal Ta-Tung Hospital, Kaohsiung, Taiwan; 2Department of Urology,
Kaohsiung Medical University Hospital, Kaohsiung, Taiwan
Purpose: We aimed to investigate the impact of preoperative hydro-
nephrosis (HN) and ﬂank pain on prognosis of patients with upper tract
urothelial carcinoma (UTUC).
Materials and Methods: In total, 472 patients with UTUC managed by
radical nephroureterectomy were included from Kaohsiung Medical Uni-
versity Hospital Healthcare System. Clinicopathological data were
collected retrospectively for analysis. The signiﬁcance of HN, especially
when combined with ﬂank pain, and other relevant factors on cancer-
speciﬁc survival (CSS) and overall survival (OS) were evaluated.
Results: Of the 472 patients, 292 (62%) had preoperative HN and 121
(26%) presented with ﬂank pain. Preoperative HN was signiﬁcantly
associated with age, ﬂank pain, tumor location, and pathological tumor
stage. Preoperative HN and ﬂank pain were signiﬁcant predictors of
non-organ-conﬁned (NOC) UTUC (p ¼ 0.020 and 0.013, respectively).
Kaplan-Meier analysis showed signiﬁcantly poorer OS and CSS in pa-
tients with preoperative HN (p ¼ 0.005 and p ¼ 0.026, respectively) and
in patients with ﬂank pain (p < 0.001 and p ¼ 0.001, respectively) than
those without. However, only simultaneous HN and ﬂank pain inde-
pendently predicted adverse outcome (HR ¼ 2.47, p < 0.001 for OS and
HR ¼ 2.28, p ¼ 0.002 for CSS, respectively) in multivariate Cox pro-
portional hazards models. Notably, there was no difference in survival
between patients with HN but devoid of ﬂank pain and those without
HN.
Conclusion: Both preoperative HN and ﬂank pain predicted NOC UTUC.
When accompanied with ﬂank pain, HN represented an independent
predictor for worse outcome in patients with UTUC.
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INFERIOR SURVIVAL, HIGHER TUMOR RECURRENCE AND PROGRESSION
RATES IN PRIMARY NON-MUSCLE-INVASIVE BLADDERCANCER WITH
IMPAIRED EGFR
Chia-En Li 2, Hui-Ying Liu 1, Chih-Hsiung Kang 1, Ye-In Chang 2, Hsiu-Pei
Tang 2. 1Department of Urology, Chang Kung Memorial Hospital,
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Purpose: To evaluate the inﬂuence of preoperative patient-associated
parameters and comorbidities, with special focus on preoperative renal
function on non-muscle-invasive bladder cancer (NMIBC) recurrence,
progression, upper urinary tract (UUT) recurrence, cancer speciﬁc survival
and overall survival.
Materials and Methods: Medical records of 158 patients with ﬁrst diag-
nosis of NMIBC from 2008 to 2010 treated at our department were
reviewed for tumor stage and grade, comorbidities, and putative risk
factors including squamous differentiation, tumor size and count, white
blood cell (WBC), neutrophil to lymphocyte ratio (NL ratio), estimated
glomerular ﬁltration rate (eGFR) by chronic kidney disease-epidemiology
collaboration formula, patient age and gender.
Results: Tumor recurrence was observed in 51 patients (32%) and UUT
recurrence was 5 patients (3%); progression to higher pT was found in 9
patients (6%). Univariate analysis revealed count, grade, size, stage, eGFR
and squamous differentiation as signiﬁcation prediction determinantsfor bladder recurrence. Count, grade, stage, eGFR were signiﬁcation
prediction determinants for progression. Age, grade, stage and eGFR
were signiﬁcation prediction determinants for overall survival. Based on
the results of multivariate analysis, a risk factor model was created to
classify patients with high and low risk of recurrence, progression and
survival.
Conclusion: eGFR, grade and stage are signiﬁcant predictive variables of
NMIBC recurrence, progression and survival. Integrating eGFR into NMIBC
risk calculation helped to discriminate individuals with high and low risk
of cancer recurrence, progression and survival. Conﬁrmatory studies and
external validation are needed to corroborate these ﬁndings.
PD8-4:
THE PREDICTIVE FACTORS FOR CONCURRENT RENAL PELVIS TUMOR OF
PATIENTS WITH URETER CARCINOMA: KAOHSIUNG CHANG GUNG
MEMORIAL HOSPITAL EXPERIENCE
Cheng-Jen Yu, Po-Hui Chiang, Hao-Lun Luo. Department of Urology,
Kaohsiung Chang Gung Memorial Hospital and Chang Gung University
College of Medicine, Kaohsiung, Taiwan
Purpose: The incidence of upper tract urothelial carcinoma (UTUC) and
chronic kidney disease (CKD) are high in southern Taiwan. The renal
sparing surgery (RSS) is an optional choice of treatment of UTUC. This
study was designed to assess the predictive factors on multifocal UTUC.
Materials and Methods: This study was retrospectively designed to
determine the predictive factors on concurrent renal pelvis urothelial
carcinoma (RPUC). From 2004 to 2012, 263 patients with preoperative
solitary ureter tumor underwent radical nephroureterectomy (RNU) at our
tertiary medical center. Perioperative data were recorded by chart review.
Multivariate binary logistic regression was used to analyze the impact of
risk factors for concurrent RPUC by SPSS ver. 17.
Results: There are thirty-eight patients (14%) had postoperative ﬁnding of
concurrent RPUC. There is no signiﬁcant difference of grade of preopera-
tive hydronephrosis between both groups (p ¼ 0.533), and there are sig-
niﬁcant difference of proportion of preoperative CKD stage (p¼ 0.005) and
past history of bladder cancer (p ¼ 0.003) between both groups. Multi-
variate analysis disclosed both bladder cancer history (odds ratio: 2.948;
p ¼ 0.005) and preoperative CKD stage >3 (odds ratio: 2.207; p ¼ 0.033)
are independent risk factors for multifocal UTUC.
Conclusion: In addition to the EAU guideline of conservative treatment for
UTUC, we supposed that past history of bladder cancer and preoperative
CKD stage greater than stage 3 are both important and independent risk
factors to synchronously multifocal UTUC. More consequent studies about
the oncologic outcome of RSS are necessary.
PD8-5:
IS THE CALCIFIED LESION OF BLADDER WALL AFTER INTRAVESICAL
MITOMYCIN-C THERAPY FOR SUPERFICIAL BLADDER CANCER SHOULD
BE RESECTED?
Jing-Dung Shen 1,2, Jane-Dar Lee 1, Tai-Lung Cha 2, Guang-Haun Sun 2, Dah-
Shyong Yu 2, Sun-Yran Chang 2, En Meng 2. 1Divisions of Urology,
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Purpose: Intravesical therapy with Mitomycin-C and Bacillus Calmette-
Guerin is a standard treatment for superﬁcial bladder cancer. Owing to the
worldwide shortage of Bacillus Calmette-Guerin, the use of Mitomycin-C
for intravesical therapy is increasing. Sometimes, calciﬁed lesion of bladder
wall at previous resection site were found during scheduled cystoscopy.
Are these lesions should be resected?
Materials and Methods: We retrospectively included 43 non-muscle
invasive bladder cancer patients who were treated with transurethral
resection of bladder tumor followed by adjuvant intravesical mitomycin C
intravesical therapy between 2011 and 2014 at Tri-service General Hos-
pital. These patients were classiﬁed into calciﬁcation and non-calciﬁcation
groups. This study analyzes the characteristic of these two groups in order
to ﬁnd the predictive factor of bladder wall calciﬁcation and the meaning
of bladder wall calciﬁcation in clinical practice.
